Wearable Devices and X-trodes Successfully Deliver Neural Interface System for Dynamic, Real-World Environments
Wearable Devices (Nasdaq: WLDS) announced on November 5, 2025 the successful completion and delivery of a jointly developed neural interface system with X-trodes for advanced tactical systems. The touchless human–machine interface uses X-trodes SmartSkin EMG patches, artifact immunity mechanisms, and Wearable Devices’ classification algorithms to enable control of communication, navigation, and command systems via subtle neuromuscular activity and gestures without manual input.
The system has been delivered to customers for evaluation and use in extreme environments, meeting operational and performance milestones, and is presented as a foundation for potential future development phases to transform interfaces in extreme environments.
Wearable Devices (Nasdaq: WLDS) ha annunciato il 5 novembre 2025 il completamento con successo e la consegna di un sistema di interfaccia neurale sviluppato congiuntamente con X-trodes per sistemi tattici avanzati. L'interfaccia uomo-macchina senza contatto utilizza patch EMG SmartSkin di X-trodes, meccanismi di immunità agli artefatti e gli algoritmi di classificazione di Wearable Devices per consentire il controllo di comunicazione, navigazione e sistemi di comando tramite attività neuromuscolare sottile e gesti, senza input manuale.
Il sistema è stato consegnato ai clienti per la valutazione e l'uso in ambienti estremi, raggiungendo traguardi operativi e di prestazione, e viene presentato come base per potenziali futuri sviluppi che mirano a trasformare le interfacce in ambienti estremi.
Wearable Devices (Nasdaq: WLDS) anunció el 5 de noviembre de 2025 la finalización y entrega exitosas de un sistema de interfaz neural desarrollado conjuntamente con X-trodes para sistemas tácticos avanzados. La interfaz humano-máquina sin contacto utiliza parches EMG SmartSkin de X-trodes, mecanismos de inmunidad a artefactos y los algoritmos de clasificación de Wearable Devices para permitir el control de la comunicación, navegación y sistemas de mando mediante actividad neuromuscular sutil y gestos sin entrada manual.
El sistema ha sido entregado a los clientes para su evaluación y uso en entornos extremos, cumpliendo metas operativas y de rendimiento, y se presenta como base para posibles fases de desarrollo futuras para transformar las interfaces en entornos extremos.
Wearable Devices (Nasdaq: WLDS)는 2025년 11월 5일에 고급 전술 시스템을 위한 X-trodes와의 공동 개발 신경 인터페이스 시스템의 성공적인 완성과 납품을 발표했습니다. 비접촉 인간-기계 인터페이스는 X-trodes SmartSkin EMG 패치, 인공물 면역 메커니즘, 그리고 Wearable Devices의 분류 알고리즘을 사용하여 수동 입력 없이 미묘한 신경근 활동과 제스처를 통해 통신, 내비게이션 및 명령 시스템을 제어합니다.
이 시스템은 극한 환경에서의 평가 및 사용을 위해 고객들에게 납품되었으며 작동 및 성능 이정을 충족하고 있으며 극한 환경에서 인터페이스를 혁신하기 위한 향후 개발 단계의 기반으로 제시됩니다.
Wearable Devices (Nasdaq: WLDS) a annoncé le 5 novembre 2025 l'achèvement et la livraison réussis d'un système d'interface neuronale développé conjointement avec X-trodes pour des systèmes tactiques avancés. L'interface homme-machine sans contact utilise des patchs EMG SmartSkin de X-trodes, des mécanismes d'immunité contre les artefacts et les algorithmes de classification de Wearable Devices pour permettre le contrôle des systèmes de communication, de navigation et de commandement via une activité neuromusculaire subtile et des gestes sans saisie manuelle.
Le système a été livré aux clients pour évaluation et utilisation dans des environnements extrêmes, atteignant des jalons opérationnels et de performance, et est présenté comme une base pour de futures phases de développement potentielles afin de transformer les interfaces dans des environnements extrêmes.
Wearable Devices (Nasdaq: WLDS) gab am 5. November 2025 die erfolgreiche Fertigstellung und Lieferung eines gemeinsam entwickelten neuronalen Schnittstellensystems mit X-trodes für fortschrittliche taktische Systeme bekannt. Die kontaktlose Mensch-Maschine-Schnittstelle verwendet X-trodes SmartSkin EMG-Patches, Artefakt-Immunitätsmechanismen und die Klassifikationsalgorithmen von Wearable Devices, um die Steuerung von Kommunikation, Navigation und Befehls Systemen über subtile neuromuskuläre Aktivität und Gesten ohne manuelle Eingabe zu ermöglichen.
Das System wurde an Kunden zur Evaluierung und Nutzung in extremen Umgebungen ausgeliefert, erfüllte operative und Leistungsmeilensteine und wird als Grundlage für potenzielle zukünftige Entwicklungsphasen präsentiert, um Schnittstellen in extremen Umgebungen zu transformieren.
Wearable Devices (Nasdaq: WLDS) أعلنت في 5 نوفمبر 2025 عن إكمال وتوصيل ناجحين لنظام واجهة عصبية مطور بشكل مشترك مع X-trodes لأنظمة تكتيكية متقدمة. تستخدم الواجهة البشرية-الآلة بدون لمس رقع EMG من X-trodes، وآليات مناعة من التشوهات، وخوارزميات التصنيف الخاصة بـ Wearable Devices لتمكين التحكم في أنظمة الاتصالات والملاحة والأوامر عبر نشاط عصبي عضلي دقيق وإيماءات بدون إدخال يدوي.
تم تسليم النظام للعملاء لتقييمه واستخدامه في بيئات قاسية، محققاً المعالم التشغيلية والأداء، ويقدم كقاعدة لمرحلة تطوير مستقبلية محتملة لتعزيز واجهات في بيئات قاسية.
- Successful delivery to customers for evaluation on Nov 5, 2025
- System integrates X-trodes SmartSkin EMG with Wearable Devices classification algorithms
- Designed for touchless control of tactical communication, navigation, and command systems
- No financial terms or revenue impact disclosed in the announcement
- No quantitative performance metrics or commercial rollout timetable provided
Insights
Successful delivery of a touchless neural HMI to customers for evaluation, meeting stated operational and performance milestones.
The project pairs Wearable Devices and X-trodes technologies to deliver a touchless neural human–machine interface that uses X-trodes SmartSkin EMG patches and Wearable Devices' classification algorithms to control tactical comms, navigation, and command systems via subtle neuromuscular activity and gestures.
Dependencies and risks include customer evaluation outcomes and any unstated integration or certification steps; the announcement confirms delivery and milestone completion but does not disclose contract size, commercial terms, or operational feedback.
Concrete items to watch over the next 6–18 months include customer evaluation reports, any announced follow-on development phases or procurement awards, and publication of performance metrics or deployment environments; the press release date is
Yokneam Illit, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced the successful completion and delivery of its neural interface system for advanced tactical systems. This milestone marks a key achievement in a strategic project executed with X-trodes, a leader in flexible bio-sensing and AI technologies for real-world environments.
The jointly developed system introduces a fully functional touchless control system based on neural human–machine interface (“HMI”) designed to enable users to control tactical communication, navigation, and command systems using subtle neuromuscular activity and intuitive gestures — without interrupting operational readiness or requiring manual input. The system utilizes X-trodes SmartSkin high performance electromyography (“EMG”) patch and artifact immunity mechanism with Wearable Devices’ classification algorithms to showcase a novel tactical HMI solution that that addresses a long-standing operational limitation — the inability to communicate and operate systems simultaneously.
This innovative collaborative system has now been successfully delivered to customers for evaluation and use in extreme environments, meeting all operational and performance milestones. It is expected to serve as a foundation for potential future phases of development aimed at transforming the current interfaces in the extreme environments space.
“We are proud to announce the successful delivery of this groundbreaking touchless control project,” said Asher Dahan, Chief Executive Officer of Wearable Devices. “Our close collaboration with X-trodes brought together the best of neural sensing and AI interpretation technologies, resulting in a solution that enhances situational awareness and control while keeping users’ eyes on mission.”
“This collaboration demonstrates how wearable neurotechnology and AI can meaningfully transform the way we use human–machines in dynamic, real-world environments,” said Dr. Ziv Peremen, Chief Executive Officer of X-trodes. “Together with Wearable Devices, we are setting a new benchmark for high-performance neural control systems capable of operating reliably even under extreme conditions.”
About Wearable Devices
Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems.
Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and extended reality (“XR”). In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from augmented reality/virtual reality/XR to smart environments.
By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world’s fastest-growing tech markets. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols “WLDS” and “WLDSW,” respectively.
About X-trodes
X-trodes is a neurotechnology company that develops flexible, medical-grade neural and bio-sensing systems for use in real-world environments. Their proprietary product, “Smart Skin”, consists of dry electrode patches that enable high-fidelity monitoring of electroencephalography (EEG), EMG, electrocardiography (ECG), and electrooculography (EOG) signals without the need for gel or laboratory conditions. The company is advancing the next generation of human-machine interactions by utilizing bioelectric signal monitoring and advanced analytics to control operational systems and assess the physiological state of the operators in the medical, defense and immersive sectors.
Forward-Looking Statements Disclaimer
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when discussing the potential benefits, applications, and future development of the neural interface system developed with X-trodes, including its ability to support next phases of development, enhance performance in extreme environments, and expand the adoption of neural human–machine interface technologies; as well as our expectations regarding continued collaboration opportunities, commercialization potential, and market acceptance of our technologies. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Investor Relations Contact
Michal Efraty
IR@wearabledevices.co.il
FAQ
What did Wearable Devices (WLDS) announce on November 5, 2025?
How does the WLDS and X-trodes neural interface control tactical systems?
Has Wearable Devices reported commercial sales or revenue from the WLDS neural interface?
What environments is the WLDS neural interface designed to operate in?
What are the next steps for the WLDS and X-trodes project?
